2022 Stanford Drug Discovery Symposium
Event summary
The 2022 Stanford Drug Discovery Symposium is intended for researchers, pharmaceutical companies, investment groups and those in the wider biomedical community, and will cover advances in research and technology that have allowed for the discovery and testing of novel diagnostics and therapies. This conference takes advantage of the collective experience and expertise of the participants to cover a broad range of policy, research and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research. Cooley Partner Madhuri Roy will speak at the event.
Event details and registration
For more information, please email Maria Russo
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.